Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 31 USD 1.11% Market Closed
Market Cap: 1.1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 56.98 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

HROW Lowest Forecast
Wall Street Target
42.42 USD
37% Upside
HROW Average Forecast
Wall Street Target
56.98 USD
84% Upside
HROW Highest Forecast
Wall Street Target
68.25 USD
120% Upside
Lowest
Price Target
42.42 USD
37% Upside
Average
Price Target
56.98 USD
84% Upside
Highest
Price Target
68.25 USD
120% Upside
Harrow Health Inc Competitors:
Price Targets
RX
Biosyent Inc
12% Upside
O
ORNBV
Orion Oyj
5% Downside
000513
Livzon Pharmaceutical Group Inc
4% Upside
J
600380
Joincare Pharmaceutical Group Industry Co Ltd
27% Upside
RX
Biosyent Inc
12% Upside
O
ORNBV
Orion Oyj
5% Downside
000513
Livzon Pharmaceutical Group Inc
4% Upside
J
600380
Joincare Pharmaceutical Group Industry Co Ltd
27% Upside
C
867
China Medical System Holdings Ltd
8% Downside
H
293480
Hana Pharm Co Ltd
48% Upside
K
GUD
Knight Therapeutics Inc
33% Upside
H
1J5
Hyphens Pharma International Ltd
15% Upside

Revenue
Forecast

Revenue Estimate
Harrow Health Inc

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 33%. The projected CAGR for the next 3 years is 40%.

33%
Past Growth
40%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Harrow Health Inc

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 199%.

N/A
Past Growth
199%
Estimated Growth
Estimates Accuracy
-20%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Harrow Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-22%
Average Miss
What are analyst estimates?

See Also

Summary
HROW intrinsic value, competitors valuation, and company profile.
DCF Valuation
HROW stock valuation using Discount Cash Flow valuation method.
Relative Valuation
HROW stock valuation using valuation multiples.
Wall Street Estimates
HROW price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
HROW stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HROW's stock price target?
Price Target
56.98 USD

According to Wall Street analysts, the average 1-year price target for HROW is 56.98 USD with a low forecast of 42.42 USD and a high forecast of 68.25 USD.

What is Harrow Health Inc's Revenue forecast?
Projected CAGR
40%

For the last 8 years the compound annual growth rate for Harrow Health Inc's revenue is 33%. The projected CAGR for the next 3 years is 40%.

What is Harrow Health Inc's Operating Income forecast?
Projected CAGR
199%

The compound annual growth rate of Harrow Health Inc's operating income for the next 3 years is 199%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 263,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.